OSMAX | WIIGX | OSMAX / WIIGX | |
Total Expense Ratio | 1.37 | 1.36 | 101% |
Annual Report Gross Expense Ratio | 1.37 | 1.38 | 99% |
Fund Existence | 28 years | 10 years | - |
Gain YTD | 19.255 | 18.852 | 102% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.66B | 218M | 1,680% |
Annual Yield % from dividends | 1.23 | 0.00 | - |
Returns for 1 year | -1.94 | -5.88 | 33% |
Returns for 3 years | 22.11 | 12.05 | 184% |
Returns for 5 years | -15.81 | -27.84 | 57% |
Returns for 10 years | 25.48 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 123.90 | N/A | N/A |
Franklin Biotechnology Discovery C | |||
VLPIX | 16.46 | N/A | N/A |
Virtus Duff & Phelps Sel MLP & Engy I | |||
OFVIX | 21.41 | N/A | N/A |
O'Shaughnessy Market Leaders Value I | |||
BRMAX | 16.05 | -0.01 | -0.06% |
iShares Russell Mid-Cap Index Inv A | |||
DFIVX | 26.95 | -0.19 | -0.70% |
DFA International Value I |